top of page
Medex EU Authorised Representative logo

EU Authorized Representative for Infusion Set Manufacturers: Rule 2, Pump Connection and the Mandate

An infusion set is a non-invasive device that channels a liquid into the body, so Rule 2 of Annex VIII to Regulation (EU) 2017/745 decides its class. A gravity administration set is class I; a set that may be connected to an infusion pump, or one that channels blood, is class IIa. The cannula, the pump and any implantable port are classified separately. For each of them a manufacturer established outside the Union must designate a sole authorized representative under Article 11, and one mandate covers the EU and Türkiye.

Rule 2 is written for infusion equipment

An administration set, extension line or infusion bag does not enter the body; it channels a liquid that will. Annex VIII handles that indirect contact in Rule 2:

"All non-invasive devices intended for channelling or storing blood, body liquids, cells or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body are classified as class IIa:" (MDR Annex VIII, Rule 2)

  • "if they may be connected to a class IIa, class IIb or class III active device; or"
  • "if they are intended for use for channelling or storing blood or other body liquids or for storing organs, parts of organs or body cells and tissues, except for blood bags; blood bags are classified as class IIb."
  • "In all other cases, such devices are classified as class I."

MDCG 2021-24 lists gravity administration sets for infusion as class I, tubing for use with an infusion pump as class IIa under the first indent, and blood lines for extracorporeal treatment under the second.

The pump connection decides between class I and class IIa

"If a device, e.g. tubing, intended to be used for a purpose that would require it to be connected to an active device, such a device will be automatically in class IIa, unless the manufacturer clearly states that it should not be connected to an active device of class IIa or higher." (MDCG 2021-24, Rule 2, practical issues)

Three branches follow:

  • A gravity set whose labelling excludes use with a pump is class I. Supplied sterile, the notified body is involved for the sterile aspects only.
  • A set labelled for use with an infusion pump, or compatible with pumps without an exclusion in the labelling, is class IIa under the first indent, because an infusion pump is a class IIb active device.
  • A transfusion set or a blood line for dialysis channels blood and is class IIa under the second indent regardless of any pump.

The cannula at the end of the line is a separate device

Under Section 3.2 of Annex VIII each component is classified in its own right. A peripheral infusion cannula stays in the vein for days, so it is a surgically invasive device for short-term use:

"All surgically invasive devices intended for short-term use are classified as class IIa unless they:" (MDR Annex VIII, Rule 7)

MDCG 2021-24 lists infusion cannulae as class IIa under Rule 7. A set sold with an integrated cannula is at least class IIa, because under Section 3.5 the strictest rule governs the combined product.

Infusion pumps and elastomeric pumps: Rule 12

"All active devices intended to administer and/or remove medicinal products, body liquids or other substances to or from the body are classified as class IIa, unless this is done in a manner that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and of the mode of application in which case they are classified as class IIb." (MDR Annex VIII, Rule 12)

MDCG 2021-24 lists infusion pumps as class IIb under the potentially hazardous branch and elastomeric pumps or balloon pumps for infusion as class IIa. Where the pump adjusts the infusion from an integrated sensor that significantly determines patient management, Rule 22 applies and the pump is class III, as it names closed loop systems; the continuous glucose monitors page covers closed-loop insulin delivery.

Implantable ports and nanomaterial coatings

"For instance, if an operation is carried out specifically to place an infusion port into the body which would remain in place for at least 30 days after the procedure, such an infusion port would be an implant." (MDCG 2021-24, Section 3.1, implantable devices)

Rule 8 then applies, and its fifth indent reads "are intended to administer medicinal products, in which case they are classified as class III;" (MDR Annex VIII, Rule 8). The manufacturer of a port settles with its notified body whether the port administers medicinal products in that sense or only channels them, because the answer decides between class IIb and class III. Either way the implant card of Article 18 applies. A set with a strongly bound nano-coating is listed by MDCG 2021-24 as class IIb under Rule 19.

Classification table for an infusion range

Product variantClassRuleNotified body
Gravity administration set, sterile, not intended for pump useI (sterile)Rule 2, last sentenceLimited to sterility, Article 52(7)(a)
Administration set or extension line for infusion pumpsIIaRule 2, first indentYes
Transfusion set, blood line for dialysis or apheresisIIaRule 2, second indentYes
Peripheral infusion cannulaIIaRule 7Yes
Elastomeric or balloon infusion pumpIIaRule 12Yes
Electronic infusion pump or syringe driverIIbRule 12, potentially hazardous branchYes
Implantable infusion port intended to remain 30 days or moreIIb or III, depending on the administering indentRule 8Yes; implant card, SSCP

Conformity assessment and what the sterile route covers

"Manufacturers of class I devices, other than custom-made or investigational devices, shall declare the conformity of their products by issuing the EU declaration of conformity referred to in Article 19 after drawing up the technical documentation set out in Annexes II and III. If those devices are placed on the market in sterile condition, have a measuring function or are reusable surgical instruments, the manufacturer shall apply the procedures set out in Chapters I and III of Annex IX, or in Part A of Annex XI." (MDR Article 52(7))

"in the case of devices placed on the market in sterile condition, to the aspects relating to establishing, securing and maintaining sterile conditions;" (MDR Article 52(7)(a))

The certificate for a sterile class I set covers sterility only. Class IIa and IIb items follow Article 52(6) and 52(4) at the notified body.

What the authorized representative mandate covers for infusion sets

The appointment turns on where the manufacturer is established, not on the class of the device:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Article 11(1))

Article 11(3) fixes the minimum tasks:

"The mandate shall require, and the manufacturer shall enable, the authorised representative to perform at least the following tasks in relation to the devices that it covers:" (MDR Article 11(3))

  • "comply with the registration obligations laid down in Article 31 and verify that the manufacturer has complied with the registration obligations laid down in Articles 27 and 29;"
  • "immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"

Infusion sets generate lot-related complaints such as leakage or occlusion, so the mandate has to say how complaints are passed on and how a field safety corrective action is supported; see serious incident reporting.

One mandate for the European Union and Türkiye

Medex Kurumsal Danışmanlık acts as EU authorized representative under EUDAMED SRN TR-AR-000057550, with offices in Ankara and İstanbul. A manufacturer of infusion sets established outside the EU and Türkiye does not need two representatives:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey." (European Commission, Notice to Stakeholders, EU-Turkey Customs Union Agreement in the field of medical devices, March 2022, section I.2)

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey." (MDCG 2022-16, footnote 1)

Our mandate covers the EU Member States and Türkiye; we are not a Swiss representative or UK Responsible Person, not a notified body, and we do not find importers or distributors. The published bands on our pricing page are €800 to 1,000 per year for class I, €1,000 to 1,300 per year for class IIa, €1,200 to 1,600 per year for class IIb, with a €0 setup fee and rates fixed for three years from signature. Registration of the same infusion sets in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, is a separate service: ÜTS registration of infusion sets in Türkiye (Turkish).

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related device categories and country pages

Related groups: syringes and needles, catheters and blood bags. All groups are listed on the medical device categories page, and the manufacturer country pages start from the EU authorized representative by country list.

Frequently asked questions

Is a gravity infusion set class I?

Yes. Rule 2 places a non-invasive device that channels a liquid for infusion in class I where it is not intended for connection to a class IIa, IIb or III active device and does not channel blood. MDCG 2021-24 lists gravity administration sets for infusion as a class I example.

Our set is compatible with pumps but we sell it for gravity use. Which class?

MDCG 2021-24 says such tubing is automatically class IIa unless the manufacturer clearly states that it should not be connected to an active device of class IIa or higher. The labelling must carry that statement for the set to stay in class I.

Which class is a transfusion set?

Class IIa. The second indent of Rule 2 covers devices intended for channelling blood or other body liquids, and MDCG 2021-24 lists devices intended to channel blood in transfusion and extracorporeal circulation there.

Is the infusion pump covered by the same classification as the set?

No. The pump is an active device classified under Rule 12, class IIb for an electronic infusion pump and class IIa for an elastomeric pump. Each product is classified in its own right under Annex VIII, Section 3.2.

Does one mandate cover the European Union and Türkiye?

Yes. Under the EU-Türkiye Customs Union a manufacturer established outside both needs one authorized representative, established in the EU or in Türkiye. Medex is established in Türkiye and holds EUDAMED SRN TR-AR-000057550.

Sources and further reading

Regulation (EU) 2017/745 on medical devices (MDR), Articles 2, 10, 11, 18, 32, 52 and 54, Annex VIII - eur-lex.europa.eu

MDCG 2021-24, Guidance on classification of medical devices (October 2021) - health.ec.europa.eu

MDCG 2022-16, Guidance on authorised representatives (Regulation (EU) 2017/745 and Regulation (EU) 2017/746) - health.ec.europa.eu

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022) - health.ec.europa.eu

Get a fixed-price EU REP quote for your infusion set and cannula range (reply within 1 business day).

Request a proposal  ·  View pricing  ·  Our EU REP service

bottom of page